1. Changes in Airway Microbiome and Inflammation with Ivacaftor Treatment in Patients with Cystic Fibrosis and the G551D Mutation;Harris;Ann Am Thorac Soc,2020
2. Risk factors for Pseudomonas aeruginosa airway infection and lung function decline in children with cystic fibrosis;Mesinele;J Cyst Fibros,2021
3. Longitudinal changes and regional variation of incident infection rates at cystic fibrosis centers;Muhlebach;J Cyst Fibros,2021
4. Comparing encounter-based and annualized chronic pseudomonas infection definitions in cystic fibrosis;Rosenfeld;J Cyst Fibros,2021
5. Comparison of microbial composition of cough swabs and sputum for pathogen detection in patients with cystic fibrosis;Fenn;J Cyst Fibros,2021